Revolutionizing India’s Surgical Prowess, Empowering Doctors for Robtic Surgery across Nation

SSII MantraM “Made in India” Surgical Robot Yatra Reaches Assam to fully train Surgeons

Dibrugarh (Assam): After an impactful series of showcases across Gujarat, SS Innovations International (SSII), the makers of India’s first indigenously developed surgical robotic system, marked a key milestone in its nationwide journey as the SSII MantraM ‘Made-in-India’ Surgical Robot Yatra arrived at ‘Tea-Garden’ city of Assam, to be a part of ASACON 2025, Assam Medical College, Dibrugarh – the Annual Conference of Assam Chapter, The Association of Surgeons of India, being held from October 24 – 26, 2025, marking a significant landmark in its Assam chapter. As part of its mission to democratize access to advanced healthcare, SS Innovations International brought the state-of-the-art SSII MantraM unit to doctors, medical students, healthcare professionals, and the general public gathered to witness the unit in action, showcasing how advanced robotic surgeries can now be guided remotely.

The Dibrugarh chapter of the Yatra fostered SSII’s vision to democratize access to advanced surgical care by offering doctors, medical students, and healthcare professionals a first-hand experience conducted within the state-of-the-art MantraM Mobile Simulation Bus. The immersive experience allowed doctors, surgeons, and medical students to experience the cutting-edge capabilities of the Mantra 3.0 surgical robotic platform, India’s indigenous innovation in surgical robotics. The initiative went beyond engaging the medical community; it provided first-hand exposure to India’s leadership in robotic surgery, inspiring the next generation and reaffirming SSII’s commitment to advancing global healthcare through proudly home-grown innovation. The program featured live demonstrations and expert training sessions, offering participants a unique opportunity to explore how robotic-assisted surgery is redefining precision, safety, and accessibility in modern surgical care. On Oct 24, the SSII MantraM Mobile Tele-Robotic Surgery Unit will remain stationed at ASACON 2025, Assam Medical College, for an additional two day-long showcase of its cutting-edge tele-robotic surgical technologies.

Speaking on this initiative, Dr. Subhash Khanna, Laparoscopic Surgeon, Founder & Director of Swagat Hospitals said“We are proud to welcome the SSII MantraM Surgical Robot Yatra team to ASACON 2025 at Assam Medical College, Dibrugarh. This initiative is a testament to India’s growing strength in medical innovation and provides our faculty and students with an invaluable opportunity to experience the future of surgical technology up close. This is a historic moment that showcases what’s possible when innovation meets purpose. It brings us closer to redefining and democratizing access to advanced surgical care, particularly in regions with limited specialist availability. This marks a transformative moment in surgical science. It’s not just about technological capability; it’s about bridging gaps in access to quality healthcare. The success of the SSII Mantra system proves that the future of safe, precise, and inclusive surgery is here, and it’s being shaped in India. Such efforts will undoubtedly encourage wider acceptance and integration of robotic surgery across medical institutions nationwide.”

The event was also graced by eminent doctors and surgeons from all across Assam, and engaging more than 500 healthcare professionals, the SSII MantraM Yatra is India’s first initiative to bring robotic surgical training directly to hospitals and medical colleges. Through these on-ground interactions, SSII is equipping doctors, surgeons, and trainees with the skills and knowledge necessary to embrace advanced surgical technologies, paving the way for wider adoption and decentralised access.

Speaking about the initiative Mr. Pankaj Kumar Poddar, Regional Sales Head- South & EastSS Innovations Internationalsaid“SSII MantraM Surgical Robot Yatra reaching Assam, Dibrugarh is a moment of immense pride for me, not just as a healthcare innovator, but as someone deeply committed to advancing India’s medical landscape. Showcasing our indigenously developed surgical robotic system at a prestigious platform like ASACON 2025, hosted by Assam Medical College in Dibrugarh, underscores the significance of this journey. The Yatra is not just about technology; it’s about transforming access to quality surgical care and bridging the healthcare ecosystem. With every city we visit, including this vibrant medical hub of Dibdrugarh, SSII MantraM reinforces SS Innovations’ mission to revolutionise healthcare, one city, one hospital, and one life at a time.”

The initiative is designed not only to connect with surgeons and medical professionals but also to engage students and local residents. By providing first-hand exposure to India’s progress in robotic surgery, the event raised awareness about the future of healthcare and spotlighted the ground-breaking achievements of SS Innovations International as a proudly Indian company driving global medical innovation.

Built on a BharatBenz 1824 chassis, the SSI MantraM unit weighs 18,500 kg and measures 11.9m (L) x 2.59m (W) x 3.49m (H). The fully modified vehicle, excluding the robotic system, costs approximately INR 1.3 Crores.

SSI Innovations custom-engineered the bus, featuring a reinforced base, actuator-based patient-side carts, and locking systems to ensure stability and calibration of the robotic arms. Its expandable cabin provides adequate space for surgical teams, while air suspension, air conditioning (maintained at 21°C ± 3°C and 55% RH), and EMI/EMC compliance protect the sensitive electronics and maintain surgical integrity.

Designed for remote and underserved areas, SSI MantraM includes backup power systems (5 kVA onboard generators, external compatibility), high-speed telecom infrastructure, and research-backed satellite connectivity for future-ready telesurgery. A 380-litre fuel tank supports long-distance travel. The unit also includes a dedicated driver’s cabin, multiple access points, and a special ramp for safe equipment movement.

Furthermore, SSI MantraM is a testament to SS Innovation’s unwavering commitment to revolutionising healthcare through innovation and precision engineering. By continuously advancing its capabilities, SSI is redefining the possibilities of healthcare. This initiative is not just about technology; it’s about breaking barriers and ensuring that life-saving, world-class surgical care reaches even the most remote and underserved communities.

Related Posts

India’s Domestic Medical Device Industry lords it over in UK Parliament

The Country moves closer to becoming Global Hub of Medical Technology London/ New Delhi:  Indian Medical Device Industry has absolutely come of age and is surely moving towards becoming global…

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients

A New Chapter of Advanced and Integrated Onco Services Begins Bengaluru: Sparsh (touch) is what is needed too to treat a cancer patient. Care and compassion is the combination that is…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Restricted pills in car lead to shadow pharmacy empire stretching from Kanpur to Ludhiana.

Restricted pills in car lead to shadow pharmacy empire stretching from Kanpur to Ludhiana.

Gang which supplied Rs100 cr codeine cough syrup busted

Gang which supplied Rs100 cr codeine cough syrup busted

Mahima Choudhary was ‘Lucky’ Cancer lurking behind her ‘Choli’ was caught early

Mahima Choudhary was ‘Lucky’ Cancer lurking behind her ‘Choli’ was caught early

Ujjain Set to Become Medical Device Manufacturing Hub: 11 Major Firms Pledge ₹600 Crore Investment, 1,700+ Jobs

Ujjain Set to Become Medical Device Manufacturing Hub: 11 Major Firms Pledge ₹600 Crore Investment, 1,700+ Jobs

Zydus Lifesciences gets USFDA nod for Leuprolide Acetate injection

Zydus Lifesciences gets USFDA nod for Leuprolide Acetate injection

Lupin launches generic injection in US with 180-day exclusivity

Lupin launches generic injection in US with 180-day exclusivity